Nedira Frenkel

Mrs. Frenkel brings a passion for science, business, and healthcare, as well as strength of strategic thinking and the ability to lead a diverse organization. She earned her B.Sc. in life sciences from Ben Gurion University. Subsequently, she obtained her M.Sc. in biochemistry at the Atlas-Leviski laboratory at the Hebrew University of Jerusalem, in collaboration with the University of Messina in Sicily, where she focused on novel therapeutics for the treatment of chlorine inhalational lung injury.

She also holds an MBA from the Recanati School of Business at Tel Aviv University. Mrs. Frenkel has been in the biotech industry for 8 years. She has served as Head of Business Development for multiple global pharmaceutical companies. She has raised over $30M in funding for technologies via venture capital and government funding.